Michael McHale

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial”.

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30180-7

N/A

5.1DataRank · unranked

233 citations

Su-Chun Cheng, Andrea E. Wahner Hendrickson, Richard T. Penson, Susan Schumer, L. Austin Doyle +19 more

Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.025

N/A

2.5DataRank · unranked

85 citations

Virginia L. Filiaci, Adrianne Mallen, Kristina W. Thiel, Eric J. Devor, Katherine Moxley +17 more

Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.04.019

N/A

0.909DataRank · unranked

18 citations

Ronghui Xu, Catheryn M. Yashar, Michael McHale, John Einck, Jyoti Mayadev +9 more

Charting a professional course for academic gynecologic oncology mentors

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.10.024

N/A

0DataRank · unranked

2 citations

Pratibha Binder, Cheryl Saenz, Ramez N. Eskander, Michael McHale, Steven C. Plaxe +1 more